Poor quality malaria drugs: how many and where? (Research brief)
Research brief
Category: Intervention Manuals
Sub Category: Intervention Manuals
Author: ACT Consortium Drug Quality Project Team
Published Date: 25 May 2015
Description
The Artemisinin-based Combination Therapy (ACT) Consortium Drug Quality programme collected and analysed the quality of over 10,000 artemisinin-based drugs from six malaria endemic countries: Cambodia, Equatorial Guinea, Ghana, Nigeria, Rwanda and Tanzania.
Previous reports had suggested that up to one third of antimalarials were “fake”. The Drug Quality programme showed that falsified antimalarials are not as common as previously reported. However, substandard drugs are present in all countries studied and monotherapy tablets are still available in some places.